[ Archive Home ]
MycoBiotech| [ Archive Home ] |
| MycoBiotech |
| Pages: 1 of 1 |
(Post 1 of 17) 03/08/2000.19:45:00 |
| Author : |
Have read recently in the Business Times that homegrown biotech company MycoBiotech will be listing soon. Mycobiotech owns the Everbloom Mushroom business...they have a technique of growing mushrooms in a shorter period. They also are involved in health related products i.e. linzir (which is a best seller). The purpose of the listing is to go global. Myco also owns a 25% stake in Everbloom Biotechnology, a US company that is aspiring towards a Nasdaq listing...with the recent fervour on Biotech counters....Mycobiotech is one to look out for. |
| (Post 2 of 17) 03/08/2000.20:52:00 |
| Author : |
Just a note of caution. For those who are interested in this company, they should study the historical background of Everbloom Mushroom and the market potential of mushroom and linzi products. |
| (Post 3 of 17) 03/08/2000.21:29:00 |
| Author : |
Thanks Yellowmoon. For those who are interested to find out more : http://www.everbloom-mushroom.com.sg/ Cultivate/Sell mushrooms also can IPO ... phew ... next better player ... Yi Hu Aquarium, Singapore Largest tropical fish researcher/importer/exporter/distributor .... okay joking. ----- Extract Company Profile -------- Dr. Tan Kok Kheng, Ph. D was an academic who turned business entrepreneur when he discovered that result of the scientific research he was doing in the National University of Singapore had far reaching health and commercial potential. The research project was on the use of agricultural waste as a source of food production. It was financed by the Stockolm International Foundation for Science. Dr. Tan discovered a shorter growing time for Shiitake mushrooms. Shiitake mushrooms in the wild and traditional methods of cultivating the mushroom took two years to mature but DR. Tan discovered a method of reducing the growth period to just six weeks. Fueled by the excitement of the discovery, and the health and bio-medical potential of Shiitake mushrooms, Dr. Tan decided to venture into the Mushroom growing business in 1980, the first in Singapore. Initial funding was a loan from the Economic Development Board's (EDB) Small Industries Finance Scheme. Everbloom was the first bio-technology firm to receive funding of this nature at a time when small industries in Singapore were mainly involved in manufacturing. This major career switch makes Dr. Tan a pioneer in Singapore agro-tech industry. He was also among the first to bridge the gap between academic R&D and business. Everbloom is one of the few bio-tech companies in S.E. Asia spearheading mushroom and fungus related research. Since its inception it has gradually changed the eating habits of Singaporeans to a preference for fresh mushrooms. Now fresh mushrooms are an essential item in their shopping baskets. Everbloom is the chief supplier of fresh mushrooms and mushroom products in Singapore. The Everbloom Mushroom farm now produces fifteen tonnes of Shiitake per month for export and local markets. Thirty tonnes of fresh mushrooms are traded every month. --------------------------- |
| (Post 4 of 17) 03/20/2000.12:51:00 |
| Author : |
For those interested to know this is the first homegrown biotech company. From the website the group has set up companies in the U.K. and North America to spearhead its worldwide expansion and is currently undergoing research to prove further the anti-cancer properties of the shiitake mushroom. |
| (Post 5 of 17) 03/21/2000.20:17:00 |
| Author : |
For those interested in seeing the products, The Mushroom Shop is located at Thompson Plaza. Mushrooms galore. |
| (Post 6 of 17) 03/21/2000.20:42:00 |
| Author : |
I seriously doubt you can call this a true biotechnology company. When you compare this to companies like Pfizer, Glaxo-Wellcome, Immunex and Medimmune, you become aware of what MycoBiotech really is... just a mushroom farm with a lab. |
| (Post 7 of 17) 03/22/2000.00:27:00 |
| Author : |
Personally, I feel the appeal in MycoBiotech lies in the fact that it has a very diversified business i.e. it has cornered the mushroom market, a food where the whole world is your potential market. They have managed to use biotech methodology to tap the health potential of the shitake mushroom...I've heard those linzir capsules really sell...furthermore, the anti-cancer benefits of the shitake is being intensively studied...whilst it may be true that Mycobiotech is not `true' biotech company like those Gasman mentioned, the reality is that they have a business where their costs is low and market potential is immense...the prospect for earnings growth is thus positive. The key to Mycobiotech's success thus lies with its marketing and distribution channels for its products. |
| (Post 8 of 17) 03/22/2000.06:48:00 |
| Author : |
I view this as more of a Cerebos type share rather than a Pfizer. They are basically selling chicken essence with mushrooms. Having said that, Warren Buffet likes Cerebos-type shares. All ex-medical students would know the boss of MycoBiotech. We used to call him The Walrus, because of his nice bushy moustache. He gave biochemistry lectures. What happened basically is that these academic types were growing Shiitake mushrooms in a cold room (the conventional way) for research, since the wisdom of the day was that you must maintain a certain low temperature for the mushrooms to survive. One day the aircon broke down overnight and they thought: Oh no, there goes this batch of mushrooms. But lo and behold, what did they see the next few days but lots and lotsa mushrooms blooming (like Internet IPO's). It seems that giving the mushrooms a "heat shock" stimulated and accelerated the growth, so that it took just 6 weeks instead of 2 years. So this guy asked himself: Now do we want to publish this in a scientific journal for the benefit of mankind, or do we want to exploit the commercial possibilities (since Shiitake mushrooms were very expensive because of the time-consuming method of cultivation)? The rest is history. Now, I wonder if you can apply "heat shocks" to certain stocks to make them grow faster as well? If I discover such a method, I think I shall publish it for the benefit of mankind, eh? |
| (Post 9 of 17) 03/22/2000.06:51:00 |
| Author : |
The cost of production is definitely low - they basically need the mushroom spores and some woodchips to grow the mushrooms on. Their advantage is basically holding the patent to this process of cultivating mushrooms. That makes it a business with a low barrier of entry - a company in, say, China, could start using the same method to produce lots of cheap Shiitake mushrooms and flood the market. Now, if they launched a Mushrooms.com IPO, that would be different.... |
| (Post 10 of 17) 04/11/2000.13:57:00 |
| Author : |
In the April issue of Smart Investor magazine, there is a report that MycoBiotech is expanding to North America and has set up a JV with Lexembourg based investment company Cambridge Mercantile Holdings. The JV has the rights to the Everbloom mushroom technology and brand in America, Canada and Mexico. Facilities to grow mushrooms will be set up in Canada this year and more plants are expected to follow in America leading to up to 12 plants. Speciality mushrooms are planned for the US market estimated at US 1 billion. These mushrooms will have health related benefits. The article concluded that CEO of MycoBiotech Dr KK Tan sees the `sky as the limit' for his products. |
| (Post 11 of 17) 07/07/2000.21:46:00 |
| Author : |
Hi Scoop! Where did you get this scoop? Is it a fact that NTUC has bought a stake or just a strong rumour? Do you know details? Is the stake significant? More importantly, does the company plan to focus purely on mushrooms or is there scope for even more into becoming a diversified life sciences holding company? Cheers! Mojo |
| (Post 12 of 17) 07/07/2000.22:18:00 |
| Author : |
 |
| (Post 13 of 17) 07/09/2000.17:33:00 |
| Author : |
What happened to Scoop's scoop? i.e. message before mine on 7 July 2000? |
| (Post 14 of 17) 07/12/2000.23:06:00 |
| Author : |
Hi Mojo, Scoop's earlier message was obviously yanked by some concerned insiders because it was too close to the truth. Scoop is definitely right on the mark. All I can say to you now is to remember what he said (and spread the good word if you dare) and save up everything you have for the first biotech IPO in Singapore! Remember, Everbloom isn't only about mushrooms. NTUC knows that. Now you do. Expect some news later this month or in August. Gotta fade into oblivion now...  |
| (Post 15 of 17) 07/12/2000.23:18:00 |
| Author : |
Hi Yurulu, Thanks, I've come to learn that Scoop's posting is still found at the IPO section of this site...read it now before it DISAPPEARS.....Cheers!! |
| (Post 16 of 17) 03/07/2001.23:20:42 |
| Author : |
Saw an ad in today's papers jointly taken out by Mycobiotech and NTUC Income for a talk on the anti-cancer value of mushrooms to be held on 17 Mar 2001. Those interested in the company may wish to attend...however, anyone with any idea when this IPO is expected? |
| (Post 17 of 17) 09/20/2002.18:18:05 |
| Author : |
Hahaha...... Agriculture Farmer Business with a few Needles
Like that also call 'Life sciences $ BioTech'! Me also life~Science n BIOtechno leh! |
| Pages: 1 of 1 |
|
Copyright © 2005 ShareInvestor Pte Ltd. All Rights Reserved. Please read our General Disclaimer & Warning carefully. Use of this Website constitutes acceptance of the Terms of Website Use. For Members, please read our Membership Terms and Conditions carefully. |
Design by InfiniteSparks
|